• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

miR-145 和 miR-133a 作为肿瘤抑制因子发挥作用，直接调控膀胱癌中 FSCN1 的表达。

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.

机构信息

Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, Japan.

出版信息

Br J Cancer. 2010 Mar 2;102(5):883-91. doi: 10.1038/sj.bjc.6605570. Epub 2010 Feb 16.

DOI:10.1038/sj.bjc.6605570
PMID:20160723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2833258/
Abstract

BACKGROUND

We have recently identified down-regulated microRNAs including miR-145 and miR-133a in bladder cancer (BC). The aim of this study is to determine the genes targeted by miR-145, which is the most down-regulated microRNA in BC.

METHODS

We focused on fascin homologue 1 (FSCN1) from the gene expression profile in miR-145 transfectant. The luciferase assay was used to confirm the actual binding sites of FSCN1 mRNA. Cell viability was evaluated by cell growth, wound-healing, and matrigel invasion assays. BC specimens were subjected to immunohistochemistry of FSCN1 and in situ hybridisation of miR-145.

RESULTS

The miR-133a as well as miR-145 had the target sequence of FSCN1 mRNA by the database search, and both microRNAs repressed the mRNA and protein expression of FSCN1. The luciferase assay revealed that miR-145 and miR-133a were directly bound to FSCN1 mRNA. Cell viability was significantly inhibited in miR-145, miR-133a, and si-FSCN1 transfectants. In situ hybridisation revealed that miR-145 expression was markedly repressed in the tumour lesion in which FSCN1 was strongly stained. The immunohistochemical score of FSCN1 in invasive BC (n=46) was significantly higher than in non-invasive BC (n=20) (P=0.0055).

CONCLUSION

Tumour suppressive miR-145 and miR-133a directly control oncogenic FSCN1 in BC.

摘要

背景

我们最近在膀胱癌（BC）中发现下调的 microRNA 包括 miR-145 和 miR-133a。本研究的目的是确定 miR-145 的靶基因，miR-145 是 BC 中下调最明显的 microRNA。

方法

我们专注于 miR-145 转染体中的基因表达谱中的 fascin 同源物 1（FSCN1）。荧光素酶测定用于确认 FSCN1 mRNA 的实际结合位点。通过细胞生长、划痕愈合和基质胶侵袭测定评估细胞活力。对 FSCN1 的 BC 标本进行免疫组织化学和 miR-145 的原位杂交。

结果

数据库搜索显示 miR-133a 和 miR-145 都有 FSCN1 mRNA 的靶序列，这两种 microRNA 均抑制 FSCN1 mRNA 和蛋白的表达。荧光素酶测定显示 miR-145 和 miR-133a 直接结合到 FSCN1 mRNA 上。miR-145、miR-133a 和 si-FSCN1 转染的细胞活力显著受到抑制。原位杂交显示 FSCN1 在 miR-145 表达明显受抑制的肿瘤病变中强烈染色。在 46 例浸润性 BC（n=46）中 FSCN1 的免疫组化评分明显高于 20 例非浸润性 BC（n=20）（P=0.0055）。

结论

肿瘤抑制性 miR-145 和 miR-133a 直接控制 BC 中的致癌 FSCN1。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383d/2833258/107da56a0f2f/6605570f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383d/2833258/7d550e8ab900/6605570f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383d/2833258/01ed9306444f/6605570f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383d/2833258/e11d6116bf62/6605570f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383d/2833258/68ab028ec5bf/6605570f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383d/2833258/107da56a0f2f/6605570f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383d/2833258/7d550e8ab900/6605570f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383d/2833258/01ed9306444f/6605570f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383d/2833258/e11d6116bf62/6605570f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383d/2833258/68ab028ec5bf/6605570f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383d/2833258/107da56a0f2f/6605570f5.jpg

相似文献

1
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.miR-145 和 miR-133a 作为肿瘤抑制因子发挥作用，直接调控膀胱癌中 FSCN1 的表达。
Br J Cancer. 2010 Mar 2;102(5):883-91. doi: 10.1038/sj.bjc.6605570. Epub 2010 Feb 16.
2
miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.miR-145、miR-133a 和 miR-133b：抑癌 miRNAs 在食管鳞癌细胞中靶向 FSCN1。
Int J Cancer. 2010 Dec 15;127(12):2804-14. doi: 10.1002/ijc.25284.
3
Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.LASP1 在细胞活力中的功能作用及其在膀胱癌中受 microRNAs 的调控。
Urol Oncol. 2012 Jul-Aug;30(4):434-43. doi: 10.1016/j.urolonc.2010.05.008. Epub 2010 Sep 16.
4
MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.miR-133a 通过直接调控 GSTP1 诱导膀胱癌细胞系凋亡。
Urol Oncol. 2013 Jan;31(1):115-23. doi: 10.1016/j.urolonc.2010.09.017. Epub 2011 Mar 10.
5
MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.微小RNA-145和微小RNA-133a通过靶向丝状肌动蛋白结合蛋白1抑制肝癌细胞的增殖、迁移和侵袭，同时促进其凋亡。
Dig Dis Sci. 2015 Oct;60(10):3044-52. doi: 10.1007/s10620-015-3706-9. Epub 2015 Jul 15.
6
MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer.微小 RNA-133a 调控食管癌中两个侵袭伪足相关蛋白（FSCN1 和 MMP14）的 mRNAs。
Br J Cancer. 2014 Jan 7;110(1):189-98. doi: 10.1038/bjc.2013.676. Epub 2013 Nov 5.
7
Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.膀胱癌中肿瘤抑制因子 microRNA-1 和 microRNA-133a 调控的新型分子靶标。
Int J Oncol. 2012 Jun;40(6):1821-30. doi: 10.3892/ijo.2012.1391. Epub 2012 Feb 29.
8
MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1.微小RNA-133a通过靶向丝状肌动蛋白成束蛋白1抑制胃癌细胞的增殖和侵袭，并诱导其凋亡。
Mol Med Rep. 2015 Jul;12(1):1473-8. doi: 10.3892/mmr.2015.3545. Epub 2015 Mar 24.
9
Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.长链非编码 RNA ZEB1-AS1 调控 miR-200b/FSCN1 信号通路，增强 TGF-β1 诱导的膀胱癌细胞迁移和侵袭。
J Exp Clin Cancer Res. 2019 Mar 1;38(1):111. doi: 10.1186/s13046-019-1102-6.
10
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.miR-1 和 miR-133a 通过靶向 TAGLN2 抑制膀胱癌的肿瘤抑制功能。
Br J Cancer. 2011 Mar 1;104(5):808-18. doi: 10.1038/bjc.2011.23. Epub 2011 Feb 8.

引用本文的文献

1
MicroRNA-145 in urologic tumors: biological roles, regulatory networks, and clinical translation.泌尿系统肿瘤中的MicroRNA-145：生物学作用、调控网络及临床转化
Front Pharmacol. 2025 Jul 4;16:1609646. doi: 10.3389/fphar.2025.1609646. eCollection 2025.
2
miRNA regulation of the Akt/mTOR pathway in oral squamous cell carcinoma: a focused review.微小RNA对口腔鳞状细胞癌中Akt/mTOR信号通路的调控：一项聚焦综述
Discov Oncol. 2025 Jul 17;16(1):1355. doi: 10.1007/s12672-025-03073-2.
3
The effect of microRNA-145 on proliferation and apoptosis of cutaneous squamous cell carcinoma cells.

本文引用的文献

1
Decreased expression of microRNA-143 and -145 in human gastric cancers.人胃癌中微小RNA - 143和 - 145表达降低。
Oncology. 2009;77(1):12-21. doi: 10.1159/000218166. Epub 2009 May 12.
2
Identification of novel microRNA targets based on microRNA signatures in bladder cancer.基于膀胱癌中微小RNA特征鉴定新型微小RNA靶标
Int J Cancer. 2009 Jul 15;125(2):345-52. doi: 10.1002/ijc.24390.
3
miR-145 inhibits breast cancer cell growth through RTKN.微小RNA-145通过Rho关联卷曲螺旋蛋白激酶抑制乳腺癌细胞生长。
微小RNA-145对皮肤鳞状细胞癌细胞增殖和凋亡的影响。
Discov Oncol. 2025 Jul 1;16(1):1201. doi: 10.1007/s12672-025-03032-x.
4
Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs.膀胱癌中的表观遗传修饰：DNA甲基化与微小RNA之间的相互作用
Front Immunol. 2025 Feb 5;16:1518144. doi: 10.3389/fimmu.2025.1518144. eCollection 2025.
5
Bladder cancer: non-coding RNAs and exosomal non-coding RNAs.膀胱癌：非编码 RNA 和外泌体非编码 RNA。
Funct Integr Genomics. 2024 Aug 31;24(5):147. doi: 10.1007/s10142-024-01433-9.
6
Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p.假基因 OCT4-pg5 通过与 miR-145-5p 竞争上调 OCT4B 的表达来促进膀胱癌的进展。
Cell Cycle. 2024 Mar;23(6):645-661. doi: 10.1080/15384101.2024.2353554. Epub 2024 Jun 6.
7
A Comparative Analysis of Naïve Exosomes and Enhanced Exosomes with a Focus on the Treatment Potential in Ovarian Disorders.天然外泌体与增强型外泌体的比较分析：聚焦于卵巢疾病的治疗潜力
J Pers Med. 2024 Apr 30;14(5):482. doi: 10.3390/jpm14050482.
8
miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers.miR-133a 和 miR-135a 通过抑制 CDX2 翻译调控全反式维甲酸诱导的小儿急性髓系白血病分化并作为预后生物标志物。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241248576. doi: 10.1177/15330338241248576.
9
Identification of novel molecules and pathways associated with fascin actin‑bundling protein 1 in laryngeal squamous cell carcinoma through comprehensive transcriptome analysis.通过全面转录组分析鉴定与喉鳞状细胞癌 Fascin 肌动蛋白结合蛋白 1 相关的新型分子和通路。
Int J Mol Med. 2024 Apr;53(4). doi: 10.3892/ijmm.2024.5363. Epub 2024 Mar 1.
10
Human Papillomavirus Infection in Penile Cancer: Multidimensional Mechanisms and Vaccine Strategies.人乳头瘤病毒感染与阴茎癌：多维机制与疫苗策略。
Int J Mol Sci. 2023 Nov 27;24(23):16808. doi: 10.3390/ijms242316808.
Int J Oncol. 2009 May;34(5):1461-6.
4
The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.假定的肿瘤抑制性微小RNA-101通过抑制多梳蛋白家族蛋白EZH2来调节癌症表观基因组。
Cancer Res. 2009 Mar 15;69(6):2623-9. doi: 10.1158/0008-5472.CAN-08-3114. Epub 2009 Mar 3.
5
The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.四种最常见卵巢癌中六种生物标志物的表达：与临床病理参数的相关性
APMIS. 2009 Mar;117(3):162-75. doi: 10.1111/j.1600-0463.2008.00003.x.
6
Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer.微小RNA-31、-143和-145在结直肠癌中的表达的临床病理意义
Dis Markers. 2009;26(1):27-34. doi: 10.3233/DMA-2009-0601.
7
Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.Fascin蛋白调节前列腺癌细胞的侵袭，并且与前列腺癌的转移及生化复发相关。
Clin Cancer Res. 2009 Feb 15;15(4):1376-83. doi: 10.1158/1078-0432.CCR-08-1789.
8
Uncovering growth-suppressive MicroRNAs in lung cancer.发现肺癌中具有生长抑制作用的微小RNA。
Clin Cancer Res. 2009 Feb 15;15(4):1177-83. doi: 10.1158/1078-0432.CCR-08-1355.
9
p53 represses c-Myc through induction of the tumor suppressor miR-145.p53通过诱导肿瘤抑制因子miR-145来抑制c-Myc。
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3207-12. doi: 10.1073/pnas.0808042106. Epub 2009 Feb 6.
10
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.微小RNA let-7d和miR-205的低水平表达是头颈部鳞状细胞癌的预后标志物。
Am J Pathol. 2009 Mar;174(3):736-45. doi: 10.2353/ajpath.2009.080731. Epub 2009 Jan 29.